Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -149,344 | -210,304 | -161,336 | -123,321 | -97,263 |
| Depreciation Amortization | 5,652 | 4,635 | -3,149 | 17 | 2,797 |
| Accounts receivable | N/A | N/A | 1,983 | 15 | 7,281 |
| Accounts payable and accrued liabilities | -5,480 | 1,428 | 2,969 | -1,351 | 891 |
| Other Working Capital | -15,939 | 9,089 | 1,251 | 4,217 | 6,917 |
| Other Operating Activity | 36,775 | 39,649 | 41,921 | 25,792 | 3,934 |
| Operating Cash Flow | $-128,336 | $-155,503 | $-116,361 | $-94,631 | $-75,443 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 134,509 | 144,188 | -126,091 | -148,444 | 75,652 |
| PPE Investments | -219 | -3,848 | -921 | -1,760 | -1,953 |
| Investing Cash Flow | $134,290 | $140,340 | $-127,012 | $-150,204 | $73,699 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 19,910 | N/A | 9,850 | N/A |
| Common Stock Issued | 570 | 3,207 | 275,252 | 217,561 | 2,984 |
| Other Financing Activity | -32,267 | 0 | -847 | -557 | -457 |
| Financing Cash Flow | $-31,697 | $23,117 | $274,405 | $226,854 | $2,527 |
| Beginning Cash Position | 72,670 | 64,716 | 33,684 | 51,665 | 50,882 |
| End Cash Position | 46,927 | 72,670 | 64,716 | 33,684 | 51,665 |
| Net Cash Flow | $-25,743 | $7,954 | $31,032 | $-17,981 | $783 |
| Free Cash Flow | |||||
| Operating Cash Flow | -128,336 | -155,503 | -116,361 | -94,631 | -75,443 |
| Capital Expenditure | -374 | -3,848 | -921 | -1,760 | -1,953 |
| Free Cash Flow | -128,710 | -159,351 | -117,282 | -96,391 | -77,396 |